You need to upgrade your Flash Player, or turn on Javascript, if not navigation can be used from the bottom of the page. QCTR Logo and header banner with navigation

10 Tips for Successful Outsourcing


Contracting is a rapidly growing area in pharmaceutical research and development – the relationship between pharma company and CRO is paramount. Susan McGoldrick at QCTR offers advice on how to build a strong partnership and achieve successful outsourcing. » Read more


Making headway in Huntington’s


From the planning stage through to running a trial and beyond, clinical studies in orphan indications have their own unique problems and particularities. Susan McGoldrick, Fiona Duffy and Crispin Bennett describe the lessons they learned in conducting a trial in Huntington’s disease. » Read more


Pivotal protocols


Just as mountain climbers need to be suitably equipped to negotiate tough terrain, sponsors of studies into orphan diseases need to have robust protocols to guide staff through the trials ahead. Susan McGoldrick focuses on developing a ‘4x4’ protocol for sponsors, regulators and investigators. » Read more


SOS from CNS


Despite massive sales of drugs for psychiatric and neurodegenerative disorders, there still remains an enormous unmet medical need in these disease areas. Susan McGoldrick at QCTR Limited reports. » Read more


QCTR to trial Huntingdon's disease drug


Stirling life sciences firm is to double in size after winning NeuroSearch clinical research contract.» Read more


Stirling test firm hails Huntington's drug breakthrough


A CLINICAL trial research company based at Stirling University Innovation Park expects to double in size after winning a key contract for a drug to treat Huntington's Disease.. » Read more


VAT Number 880 3892 93  ||  Company Registration Number: 289921
© 2006 QCTR Ltd.  ||  Web Design by Farmore IT Ltd.